Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine B Breitenlechner

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta|November 5, 2005
Crystallography for protein kinase drug design: PKA and SRC case studiesChristine B Breitenlechner, Dirk Bossemeyer, Richard A Engh
The Journal of Biological Chemistry|March 5, 2004
The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase AMichael Gassel, Christine B Breitenlechner, Norbert König, et al.
Biochemistry|May 8, 2002
Phosphorylation and flexibility of cyclic-AMP-dependent protein kinase (PKA) using (31)P NMR spectroscopyMarkus H J Seifert, Christine B Breitenlechner, Dirk Bossemeyer, et al.
The Journal of Biological Chemistry|May 16, 2006
Structural analysis of protein kinase A mutants with Rho-kinase inhibitor specificityStefan Bonn, Saturnino Herrero, Christine B Breitenlechner, et al.
Journal of Molecular Biology|June 12, 2003
Mutants of protein kinase A that mimic the ATP-binding site of protein kinase B (AKT)Michael Gassel, Christine B Breitenlechner, Petra Rüger, et al.
Journal of Molecular Biology|September 20, 2005
Crystal structures of active SRC kinase domain complexesChristine B Breitenlechner, Norman A Kairies, Konrad Honold, et al.
Journal of Medicinal Chemistry|March 5, 2004
Structure-based optimization of novel azepane derivatives as PKB inhibitorsChristine B Breitenlechner, Thomas Wegge, Laurent Berillon, et al.
Journal of Medicinal Chemistry|January 7, 2005
Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase A and mutantsChristine B Breitenlechner, Walter-Gunar Friebe, Emmanuel Brunet, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|November 5, 2005
Crystallography for protein kinase drug design: PKA and SRC case studiesChristine B Breitenlechner, Dirk Bossemeyer, Richard A Engh
The Journal of Biological Chemistry|March 5, 2004
The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase AMichael Gassel, Christine B Breitenlechner, Norbert König, et al.
Biochemistry|May 8, 2002
Phosphorylation and flexibility of cyclic-AMP-dependent protein kinase (PKA) using (31)P NMR spectroscopyMarkus H J Seifert, Christine B Breitenlechner, Dirk Bossemeyer, et al.
The Journal of Biological Chemistry|May 16, 2006
Structural analysis of protein kinase A mutants with Rho-kinase inhibitor specificityStefan Bonn, Saturnino Herrero, Christine B Breitenlechner, et al.
Journal of Molecular Biology|June 12, 2003
Mutants of protein kinase A that mimic the ATP-binding site of protein kinase B (AKT)Michael Gassel, Christine B Breitenlechner, Petra Rüger, et al.
Journal of Molecular Biology|September 20, 2005
Crystal structures of active SRC kinase domain complexesChristine B Breitenlechner, Norman A Kairies, Konrad Honold, et al.
Journal of Medicinal Chemistry|March 5, 2004
Structure-based optimization of novel azepane derivatives as PKB inhibitorsChristine B Breitenlechner, Thomas Wegge, Laurent Berillon, et al.
Journal of Medicinal Chemistry|January 7, 2005
Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase A and mutantsChristine B Breitenlechner, Walter-Gunar Friebe, Emmanuel Brunet, et al.
Pageof 1